Gala vs Lemonaid Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Lemonaid Health beats Gala overall, scoring 7.2/10 vs 7/10. Lemonaid Health is more affordable at $49/mo vs $149/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Lemonaid Health for users who want a low-cost $49/mo membership with flexible me.
A side-by-side comparison of Gala and Lemonaid Health covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaLemonaid Health
#35 of 42Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).
Visit Lemonaid Health| Feature | Gala | Lemonaid Health |
|---|---|---|
| Our Score | 7/10 | 7.2/10 |
| Starting Price | $149/mo | $49/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want a low-cost $49/mo membership with flexible medication options — compounded, microdose, or brand-name Zepbound via LillyDirect |
| Ranking | #40 | #35 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Lemonaid Health
Pros
- +2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Established since 2013 with physician-only prescribing and rigorous intake
Cons
- −Membership and medication billed separately — the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
- −Best compounded pricing requires a 6-month commitment
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
Our Verdict
Lemonaid Health edges out Gala with a score of 7.2/10 vs 7/10. If budget is your priority, Lemonaid Health starts at $49/mo compared to Gala's $149/mo. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Lemonaid Health if you want: users who want a low-cost $49/mo membership with flexible medication options — compounded, microdose, or brand-name zepbound via lillydirect.